基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
With a background in tumor pathology, Dr Shibata led large-scale genomic sequencing studies of intractable solid cancers such as those of the liver and biliary tract in Asia and rare cancers, including sarcomas. He has elucidated how carcinogens induce cancers and identified molecular pathway aberrations and contributed to developing new treatments and molecular diagnoses. Dr. Shibata has also led the Liver, Biliary and Gastric Cancer Genome Analysis as the Principal Investigator of the Japanese Group at the International Cancer Genome Consortium (ICGC). Currently, Dr. Shibata participates in several international projects such as the ICGC-ARGO, the successor to ICGC, and Mutographs of Cancer - CRUK Grand Challenge Project; the latter analyzes mutation signatures by global collaboration with WHO/IARC (International Agency for Research on Cancer) and the Wellcome Sanger Institute in the United Kingdom.
He is recognized for his global and unique research in the cancer genomics field.
He is recognized for his global and unique research in the cancer genomics field.
Research Interests
Papers共 91 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cell genomicsno. 3 (2024): 100500-100500
crossref(2023)
crossref(2023)
crossref(2023)
crossref(2023)
CANCER SCIENCE (2023): 1777-1777
Cited0Views0Bibtex
0
0
Load More
Author Statistics
#Papers: 91
#Citation: 5239
H-Index: 26
G-Index: 43
Sociability: 7
Diversity: 3
Activity: 47
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn